Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 3/20 | 0.41 |
| ▸ | TP53 | P04637 | 4/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | POLB | P06746 | 3/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18407979 | 0.87 | TP53 (0.49) | THRBTP53LMNAPOLBTDP1 | |
| SCHEMBL21707955 | 0.83 | HTR2B (0.43) | THRBTP53LMNAPOLBTDP1 | |
| SCHEMBL16257366 | 0.83 | HTR2B (0.43) | THRBTP53LMNAPOLBTDP1 | |
| SCHEMBL16236804 | 0.81 | TP53 (0.46) | THRBTP53LMNAPOLBTDP1 | |
| SCHEMBL18407881 | 0.76 | POLB (0.44) | THRBTP53LMNAPOLBTDP1 | |
| SCHEMBL16257327 | 0.75 | THRB (0.43) | THRBTP53LMNAPOLBTDP1 | |
| SCHEMBL17700845 | 0.73 | HTR2B (0.53) | THRBTP53LMNAPOLBTDP1 | |
| SCHEMBL21727535 | 0.73 | POLB (0.45) | THRBTP53LMNAPOLBTDP1 | |
| SCHEMBL16237617 | 0.72 | MEN1 (0.44) | THRBTP53LMNAPOLBTDP1 | |
| SCHEMBL17700935 | 0.72 | MEN1 (0.44) | THRBTP53LMNAPOLBTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3121164-A1 | SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B | Janssen Sciences Ireland UC (IE) | 2017-01-25 | — | — | EP | disclosed |